The chromophobe tumor grading system is the preferred grading scheme for chromophobe renal cell carcinoma
- PMID: 22014797
- DOI: 10.1016/j.juro.2011.07.068
The chromophobe tumor grading system is the preferred grading scheme for chromophobe renal cell carcinoma
Abstract
Purpose: The prognostic usefulness of the Fuhrman nuclear grading system has been questioned for chromophobe renal cell carcinoma due to its frequent nuclear and nucleolar pleomorphism. Chromophobe tumor grade, a novel 3-tier tumor grading system based on geographic nuclear crowding and anaplasia, was recently reported to be superior to the Fuhrman system. We compared the 2 scoring systems in a large sporadic chromophobe renal cell carcinoma cohort to determine which grading scheme provides the most predictive assessment of clinical risk.
Materials and methods: We identified a total of 84 cases of sporadic chromophobe renal cell carcinoma in 82 patients from a total of 2,634 cases (3.2%) spanning 1989 to 2010. A subset of 11 tumors had secondary areas of sarcomatoid transformation. All cases were reviewed for Fuhrman nuclear grade and chromophobe tumor grade according to published parameters by an expert genitourinary pathologist blinded to clinicopathological information.
Results: The distribution of Fuhrman nuclear grades 1 to 4 was 0%, 52.4%, 32.9% and 14.7% of cases, and the distribution of chromophobe tumor grades 1 to 3 was 48.8%, 36.5% and 14.7%, respectively. Metastasis developed in 20 patients (24.4%). Survival analysis revealed statistically significant differences in recurrence-free survival when adjusted for chromophobe tumor grade and Fuhrman nuclear grade. Chromophobe tumor grade showed a slightly higher AUC for recurrence-free survival and overall survival than the Fuhrman nuclear grading system. Neither chromophobe tumor grade nor Fuhrman nuclear grade was retained as an independent predictor of outcome in multivariate modeling when patients with sarcomatoid lesions were excluded.
Conclusions: Chromophobe tumor grade effectively stratifies patients with chromophobe renal cell carcinoma across all grading levels. Since it does not rely on nuclear features, it avoids the hazard of overestimating the malignant potential of chromophobe renal cell carcinoma. Overall chromophobe tumor grade has higher predictive accuracy than the Fuhrman nuclear grading system.
Copyright © 2011 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.
Similar articles
-
A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade.Am J Surg Pathol. 2010 Sep;34(9):1233-40. doi: 10.1097/PAS.0b013e3181e96f2a. Am J Surg Pathol. 2010. PMID: 20679882
-
Fuhrman grading is not appropriate for chromophobe renal cell carcinoma.Am J Surg Pathol. 2007 Jun;31(6):957-60. doi: 10.1097/01.pas.0000249446.28713.53. Am J Surg Pathol. 2007. PMID: 17527087
-
Grading of clear cell renal cell carcinoma should be based on nucleolar prominence.Am J Surg Pathol. 2011 Aug;35(8):1134-9. doi: 10.1097/PAS.0b013e318220697f. Am J Surg Pathol. 2011. PMID: 21716085
-
Grading systems in renal cell carcinoma.J Urol. 2007 Feb;177(2):430-6. doi: 10.1016/j.juro.2006.09.034. J Urol. 2007. PMID: 17222604 Review.
-
[Reproducibility of Fuhrman nuclear grade: advantages of a two-grade system].Prog Urol. 2006 Jun;16(3):281-5. Prog Urol. 2006. PMID: 16821337 Review. French.
Cited by
-
Relating prognosis in chromophobe renal cell carcinoma to the chromophobe tumor grading system.Korean J Urol. 2014 Apr;55(4):239-44. doi: 10.4111/kju.2014.55.4.239. Epub 2014 Apr 10. Korean J Urol. 2014. PMID: 24741411 Free PMC article.
-
Pathologic validation of renal cell carcinoma histology in the Surveillance, Epidemiology, and End Results program.Urol Oncol. 2014 Jan;32(1):23.e9-13. doi: 10.1016/j.urolonc.2012.08.011. Epub 2013 Feb 28. Urol Oncol. 2014. PMID: 23453468 Free PMC article.
-
Diagnostic approach to eosinophilic renal neoplasms.Arch Pathol Lab Med. 2014 Nov;138(11):1531-41. doi: 10.5858/arpa.2013-0653-RA. Arch Pathol Lab Med. 2014. PMID: 25357116 Free PMC article. Review.
-
[The WHO/ISUP grading system for renal carcinoma].Pathologe. 2016 Jul;37(4):355-60. doi: 10.1007/s00292-016-0171-y. Pathologe. 2016. PMID: 27271258 German.
-
Selected tumor markers in the routine diagnosis of chromophobe renal cell carcinoma.Arch Med Sci. 2016 Aug 1;12(4):856-63. doi: 10.5114/aoms.2015.51188. Epub 2016 Mar 4. Arch Med Sci. 2016. PMID: 27478468 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical